1. At the Speed of SOUND: The Pace of Change for Axillary Management in Breast Cancer

   • Theresa Schwartz

   ASO Perspectives 12 February 2024 Pages: 2801 - 2803

2. Does Cancer Accreditation Designation Mean Better Quality Care and Long-Term Oncological Outcomes?

   • Kathie-Ann Joseph

   Global Health Services Research 22 January 2024 Pages: 2804 - 2805

3. Differences in DVT Rates in Patients Treated With and Without Preoperative Chemotherapy Prior to Distal Pancreatectomy: Is it the Therapy or Disease Burden?

   • Joshua N. Herb
   • Rebecca A. Snyder

   Pancreatic Tumors 20 January 2024 Pages: 2806 - 2808

4. Pancreatic Neuroendocrine Tumors and Lymph Nodes: How Much Surgery is Enough?

   • Eric H. Liu

   Pancreatic Tumors 27 January 2024 Pages: 2809 - 2810

5. Editorial Comment on: Cancer-Associated Fibroblast-Derived IL-8 Upregulates PD-L1 Expression in Gastric Cancer Through the NF-κB Pathway

   • Takehiko Yokobori

   Gastrointestinal Oncology 12 February 2024 Pages: 2811 - 2812

6. Disease-Specific Surgical Benchmarking: A Nuanced Approach to Operative Outcomes

   • Sanket Srinivasa

   Hepatobiliary Tumors 20 February 2024 Pages: 2813 - 2814

7. Comment on “Neoadjuvant Chemotherapy or Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Real-World Data Comparison from a Japanese Nationwide Study”

   • Caroline Gronnier

   Thoracic Oncology 14 February 2024 Pages: 2815 - 2817

8. Surgical Resection Delays among Patients with Stage 1 Lung Cancer: A Study with Disaggregated Ethnic Groups

   • Bahaa Kazzi
   • Nikhil P. Mankuzhy
   • Edward Christopher Dee

   ASO Research Letter 28 January 2024 Pages: 2818 - 2823

   

9. Updated Analysis of a Phase 2 Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Peritoneal Carcinoma from Gastric Cancer

   • Brian Badgwell
   • Jeannelyn Estrella
   • Paul Mansfield

   ASO Research Letter 29 January 2024 Pages: 2824 - 2825

   

10. Understanding the Caregiver Perspective: The Impact of Caring for Patients with Advanced Cancer

    • Beatrice J. Sun
    • Byrne Lee

    ASO Research Letter 29 January 2024 Pages: 2826 - 2828

    

11. Surgical Oncology Heroes and Legends: Kirby I. Bland MD, FACS, MAMSE as Interviewed by V. Suzanne Klimberg, MD, PhD, MSHCT, MAMSE

    • Kirby I. Bland
    • V. Suzanne Klimberg

    Global Health Services Research 13 February 2024 Pages: 2829 - 2830

12. Surgical Oncology Heroes and Legends: Edward M. Copeland III, MD, as Interviewed by Kirby I. Bland, MD, FACS, MAMSE

    • Edward M. Copeland III
    • Kirby I. Bland

    Global Health Services Research 28 February 2024 Pages: 2831 - 2832

13. Ernst Bertner: A Surgeon with Prescient Vision for the Largest Medical Center in the World

    • Charles M. Balch

    Global Health Services Research 07 February 2024 Pages: 2833 - 2855

    

14. Variation in Hospital Mortality After Complex Cancer Surgery: Patient, Volume, Hospital or Social Determinants?

    • Muhammad Musaab Munir
    • Selamawit Woldesenbet
    • Timothy M. Pawlik

    Global Health Services Research Open access 09 January 2024 Pages: 2856 - 2866

    

15. ASO Author Reflections: Variation in Hospital Mortality After Complex Cancer Surgery: Patient, Volume, Hospital, or Social Determinants?

    • Muhammad Musaab Munir
    • Timothy M. Pawlik

    ASO Author Reflections Open access 11 January 2024 Pages: 2867 - 2868

16. ASO Visual Abstract: Variation in Hospital Mortality After Complex Cancer Surgery—Patient, Volume, Hospital, or Social Determinants?

    • Muhammad Musaab Munir
    • Selamawit Woldesenbet
    • Timothy M. Pawlik

    ASO Visual Abstract 10 February 2024 Pages: 2869 - 2870

17. ASO Visual Abstract: Access, Outcomes, and Costs Associated with Surgery for Malignancy Among People Experiencing Homelessness

    • Casey M. Silver
    • Lauren M. Janczewski
    • Ryan P. Merkow

    ASO Visual Abstract 17 January 2024 Pages: 2871 - 2872

18. Neoadjuvant Chemotherapy is Associated with Increased Risk of Postoperative DVT After Distal Pancreatectomy for Pancreatic Adenocarcinoma: a NSQIP Analysis

    • Keenan J. Robbins
    • Kenneth F. Newcomer Jr.
    • William G. Hawkins

    Pancreatic Tumors 27 December 2023 Pages: 2873 - 2881

19. Accuracy and Prognostic Impact of Nodal Status on Preoperative Imaging for Management of Pancreatic Neuroendocrine Tumors: A Multi-Institutional Study

    • Nan Zhang
    • Jin He
    • Timothy M. Pawlik

    Pancreatic Tumors 14 December 2023 Pages: 2882 - 2891

    

20. Adjuvant Therapy After Upfront Resection of Resectable Pancreatic Cancer: Patterns of Omission and Use—A Prospective Real-Life Study

    • Salvatore Paiella
    • Giuseppe Malleo
    • Roberto Salvia

    Pancreatic Tumors Open access 29 January 2024 Pages: 2892 - 2901

    

21. Using a CA19-9 Tumor Marker Gene Test to Assess Outcome After Pancreatic Cancer Surgery

    • Yohei Ando
    • Mohamad Dbouk
    • Michael Goggins

    Pancreatic Tumors 06 February 2024 Pages: 2902 - 2912

    

22. Prognostic Value of Myosteatosis and Creatinine-to-Cystatin C Ratio in Patients with Pancreatic Cancer Who Underwent Radical Surgery

    • Shenghua Bi
    • Yueping Jiang
    • Xue Jing

    Pancreatic Tumors 06 February 2024 Pages: 2913 - 2924

    

23. Medicaid Expansion Increases Access for Rural and Impoverished Patients with Pancreatic Ductal Adenocarcinoma in Southern States

    • Hemanth Venkatesh
    • Tingting Li
    • Quyen D. Chu

    Pancreatic Tumors 15 February 2024 Pages: 2925 - 2931

24. Prognostic Significance of Biologic Factors in Patients with a Modest Radiologic Response to Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancers: Impact of the Combination Index of Sialyl-Lewis Antigen-Related Tumor Markers

    • Satoru Miyahara
    • Hidenori Takahashi
    • Hidetoshi Eguchi

    Pancreatic Tumors 17 February 2024 Pages: 2932 - 2942

    

25. Early Versus Late Drainage Removal in Patients Who Underwent Pancreaticoduodenectomy: A Comprehensive Systematic Review and Meta-analysis of Randomized Controlled Trials Using Trial Sequential Analysis

    • Claudio Ricci
    • Davide Giovanni Grego
    • Riccardo Casadei

    Pancreatic Tumors Open access 24 February 2024 Pages: 2943 - 2950

    

26. Vasohibin-1 Expression Can Predict Pathological Complete Remission of Advanced Bladder Cancer with Neoadjuvant Chemotherapy

    • Minami Omura
    • Takeo Kosaka
    • Mototsugu Oya

    Pancreatic Tumors Open access 20 February 2024 Pages: 2951 - 2958

    

27. ASO Author Reflections: Adjuvant Therapy for Resectable Pancreatic Cancer in the Real World—Not as Common as One Might Think

    • Salvatore Paiella
    • Giuseppe Malleo
    • Roberto Salvia

    ASO Author Reflections 13 February 2024 Pages: 2959 - 2960

28. ASO Author Reflections: Using a CA19-9 Tumor Marker Gene Test to Assess Outcome after Pancreatic Cancer Surgery

    • Yohei Ando
    • Michael Goggins

    ASO Author Reflections 27 January 2024 Pages: 2961 - 2962

29. ASO Author Reflections: Impact of Myosteatosis and Creatinine-to-Cystatin C Ratio on Prognosis After Pancreatic Radical Surgery

    • Shenghua Bi
    • Xue Jing

    ASO Author Reflections 09 February 2024 Pages: 2963 - 2964

30. ASO Author Reflections: A Role for Extended VTE Prophylaxis After Neoadjuvant Therapy and Distal Pancreatectomy for Pancreatic Adenocarcinoma

    • Keenan J. Robbins
    • William G. Hawkins

    ASO Author Reflections 12 January 2024 Pages: 2965 - 2966

31. ASO Author Reflections: The Role of Neoadjuvant Chemotherapy in Invasive Intraductal Mucinous Neoplasms of the Pancreas

    • A. Fogliati
    • Mark J. Truty

    ASO Author Reflections Open access 14 March 2024 Pages: 2967 - 2968

32. ASO Author Reflections: Feasibility of Indocyanine Green Fluorescence Technique in Robotic Duodenum-Preserving Pancreatic Head Resection

    • Yan Li
    • Baoyong Zhou

    ASO Author Reflections 26 January 2024 Pages: 2969 - 2970

33. ASO Author Reflections: A Novel Combination Index of Sialyl-Lewis Antigen-Related Tumor Markers Enhances Predictive Significance in Patients with a Modest Radiological Response to Neoadjuvant Treatment for Pancreatic Cancer

    • Satoru Miyahara
    • Hidenori Takahashi
    • Hidetoshi Eguchi

    ASO Author Reflections 16 February 2024 Pages: 2971 - 2972

34. ASO Author Reflections: Accuracy and Prognostic Impact of Nodal Status on Preoperative Imaging for Management of Pancreatic Neuroendocrine Tumors

    • Nan Zhang
    • Xu-Feng Zhang
    • Timothy M. Pawlik

    ASO Author Reflections 23 December 2023 Pages: 2973 - 2974

35. ASO Visual Abstract: Accuracy and Prognostic Impact of Nodal Status on Preoperative Imaging for Management of Pancreatic Neuroendocrine Tumors—A Multi-Institutional Study

    • Nan Zhang
    • Jin He
    • Timothy M. Pawlik

    ASO Visual Abstract 15 January 2024 Pages: 2975 - 2976

36. ASO Visual Abstract: Adjuvant Therapy After Upfront Resection of Resectable Pancreatic Cancer: Patterns of Omission and Use—A Prospective Real-Life Study

    • Salvatore Paiella
    • Giuseppe Malleo
    • Roberto Salvia

    ASO Visual Abstract 14 February 2024 Pages: 2977 - 2978

37. ASO Visual Abstract: Using a CA19-9 Tumor Marker Gene Test to Assess Outcome After Pancreatic Cancer Surgery

    • Yohei Ando
    • Mohamad Dbouk
    • Michael Goggins

    ASO Visual Abstract 14 February 2024 Pages: 2979 - 2980

38. ASO Visual Abstract: Prognostic Value of Myosteatosis and Creatinine-to-Cystatin-C Ratio in Patients with Pancreatic Cancer Who Underwent Radical Surgery

    • Shenghua Bi
    • Yueping Jiang
    • Xue Jing

    ASO Visual Abstract 07 March 2024 Pages: 2981 - 2982

39. Cancer-Associated Fibroblast-Derived IL-8 Upregulates PD-L1 Expression in Gastric Cancer Through the NF-κB Pathway

    • Meiyue Lou
    • Masaaki Iwatsuki
    • Hideo Baba

    Gastrointestinal Oncology 25 November 2023 Pages: 2983 - 2995

    

40. Comparison of Octreotide and Vasopressors as First-Line Treatment for Intraoperative Carcinoid Crisis

    • Belinda H. McCully
    • Kaiya Kozuma
    • Rodney F. Pommier

    Gastrointestinal Oncology 16 January 2024 Pages: 2996 - 3002

    

41. Laparoscopic Dissection of Lymph Node Station 16—Why and How?

    • William Kawahara
    • Eduardo A. Vega
    • Claudius Conrad

    Gastrointestinal Oncology 27 February 2024 Pages: 3003 - 3004

42. Predictive Value of a New Muscle Parameter in Patients with Resectable Gastric Cancer: A Pooled Analysis of Three Prospective Trials

    • Qing Zhong
    • Jiao-Bao Huang
    • Ping Li

    Gastrointestinal Oncology Open access 25 January 2024 Pages: 3005 - 3016

    

43. Detection and Management of Perioperative Hyperglycemia at a Tertiary Cancer Center

    • Jolyn S. Taylor
    • Bryan M. Fellman
    • Sonali Thosani

    Gastrointestinal Oncology 12 February 2024 Pages: 3017 - 3023

    

44. Long-Term Outcome of Proximal Gastrectomy for Upper-Third Advanced Gastric and Siewert Type II Esophagogastric Junction Cancer Compared With Total Gastrectomy: A Propensity Score-Matched Analysis

    • Seungho Lee
    • Yoon Soo Chae
    • Han-Kwang Yang

    Gastrointestinal Oncology Open access 19 February 2024 Pages: 3024 - 3030

    

45. ASO Author Reflections: Lymph Node Station 16 Status—Becoming a Student of Your Patients’ Cancer

    • Oscar Salirrosas
    • William Kawahara
    • Claudius Conrad

    ASO Author Reflections 29 February 2024 Pages: 3031 - 3032

46. ASO Author Reflections: COL8A1 Regulates Esophageal Squamous Carcinoma

    • Jing Hu
    • Senxiang Yan

    ASO Author Reflections 15 February 2024 Pages: 3033 - 3033

47. ASO Visual Abstract: Multimodal Therapy Versus Primary Surgery for Gastric and Gastroesophageal Junction Diffuse Type Carcinoma, with a Focus on Signet Ring Cell Carcinoma: A Nationwide Study

    • Emma C. Gertsen
    • Arjen van der Veen
    • Jelle P. Ruurda

    ASO Visual Abstract 19 January 2024 Pages: 3034 - 3035

48. ASO Visual Abstract: The Association between Intraoperative Compromised Intestinal Integrity and Postoperative Complications in Cancer Patients

    • Sharon Hendriks
    • Monique Huisman
    • Jacco J. de Haan

    ASO Visual Abstract 17 January 2024 Pages: 3036 - 3037

49. ASO Visual Abstract: Preoperative Frailty and Malnutrition in Surgical Oncology Patients Predicts Higher Postoperative Adverse Events and Worse Survival—Results of a Blinded, Prospective Trial

    • Nazanin Khajoueinejad
    • Elad Sarfaty
    • Noah A. Cohen

    ASO Visual Abstract 15 January 2024 Pages: 3038 - 3039

50. ASO Visual Abstract: Postoperative Complications After Neoadjuvant Chemotherapy Compared with Upfront Surgery in Gastric Adenocarcinoma—A Population-Based, Nationwide Study in Finland

    • Emilia Putila
    • Olli Helminen
    • the FINEGO Group

    ASO Visual Abstract 29 January 2024 Pages: 3040 - 3041